| 1 | Hallux valgus (acquired) | FING00000601 | 88.03 |
| 2 | Inguinal hernia | FING00000681 | 73.72 |
| 3 | Osteoporosis, osteopenia and pathological fracture (PheCode 743) | GCST90476258 | 53.83 |
| 4 | Intraocular pressure (confirmatory factor analysis Factor 26) | GCST90309360 | 53.33 |
| 5 | Hip index | GCST012229 | 51.35 |
| 6 | Hernia | FING00000616 | 50.29 |
| 7 | Abdominal hernia | digestive | UKBB00000002 | 50.06 |
| 8 | Pulse pressure | GCST90301703 | 49.97 |
| 9 | Intra-ocular pressure, Goldmann-correlated (left) | Intraocular pressure | UKBB00000376 | 49.40 |
| 10 | Inguinal hernia | digestive | UKBB00000362 | 49.40 |
| 11 | Operative procedures - Primary repair of inguinal hernia using insert of prosthetic material | Summary Operations | UKBB00000587 | 49.35 |
| 12 | Inguinal hernia | Hernia | UKBB00000363 | 48.10 |
| 13 | CBLN4 levels | GCST90468554 | 47.77 |
| 14 | Waist-hip index | GCST90020027 | 45.87 |
| 15 | A body shape index | GCST90020024 | 45.83 |
| 16 | Waist-to-hip ratio adjusted for BMI | GCST90020025 | 45.42 |
| 17 | Pulse pressure | GCST90472785 | 44.87 |
| 18 | Intra-ocular pressure, Goldmann-correlated (right) | Intraocular pressure | UKBB00000377 | 44.48 |
| 19 | Abdominal hernia (PheCode 550) | GCST90476059 | 42.88 |
| 20 | Impedance of arm left (UKB data field 23110) | GCST90468171 | 42.45 |
| 21 | Impedance of arm right (UKB data field 23109) | GCST90468172 | 41.97 |
| 22 | Hip index | GCST90020026 | 41.48 |
| 23 | HSPG2/IGFBP6 ratio | GCST90315091 | 41.26 |
| 24 | Waist circumference adjusted for body mass index | GCST90020029 | 41.11 |
| 25 | VNN2 levels | GCST90618510 | 41.01 |
| 26 | Pulse pressure | GCST90301701 | 40.28 |
| 27 | Carpal tunnel syndrome | FING00000257 | 39.69 |
| 28 | Autorefraction - 6mm asymmetry index (right) | Eyesight | UKBB00000074 | 39.52 |
| 29 | Osteoporosis NOS (PheCode 743.11) | GCST90476260 | 39.31 |
| 30 | Heel Broadband ultrasound attenuation, direct entry | Bone-densitometry of heel | UKBB00000321 | 38.12 |
| 31 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 42) | GCST90320605 | 37.96 |
| 32 | Oblique pelvic inlet length | GCST90448909 | 37.83 |
| 33 | Hip width to body height ratio | GCST90270260 | 37.70 |
| 34 | Osteoporosis (PheCode 743.1) | GCST90476259 | 36.14 |
| 35 | Heel bone mineral density (BMD) (left) | Bone-densitometry of heel | UKBB00000313 | 35.65 |
| 36 | ROBO2 levels | GCST90470490 | 34.99 |
| 37 | Other specified and unspecified disorders of lens | FING00001101 | 34.69 |
| 38 | Heel quantitative ultrasound index (QUI), direct entry (left) | Bone-densitometry of heel | UKBB00000322 | 34.64 |
| 39 | Heel bone mineral density (BMD) T-score, automated (left) | Bone-densitometry of heel | UKBB00000316 | 34.63 |
| 40 | Central corneal thickness | GCST006366 | 34.52 |
| 41 | Heel quantitative ultrasound index (QUI), direct entry (right) | Bone-densitometry of heel | UKBB00000323 | 32.43 |
| 42 | Heel bone mineral density (BMD) T-score, automated (right) | Bone-densitometry of heel | UKBB00000317 | 32.42 |
| 43 | Impedance of arm (right) | Impedance measures | UKBB00000357 | 32.35 |
| 44 | Gout (PheCode 274.1) | GCST90043662 | 32.23 |
| 45 | Autorefraction - 6mm strong meridian (left) | Eyesight | UKBB00000075 | 31.97 |
| 46 | Heel broadband ultrasound attenuation (left) | Bone-densitometry of heel | UKBB00000319 | 31.92 |
| 47 | Heel bone mineral density (BMD) (right) | Bone-densitometry of heel | UKBB00000314 | 31.84 |
| 48 | Prescriptions - latanoprost | prostaglandin analog | UKBB00000686 | 31.77 |
| 49 | Impedance of arm (left) | Impedance measures | UKBB00000356 | 31.46 |
| 50 | Bone density (confirmatory factor analysis Factor 19) | GCST90309353 | 31.40 |
| 51 | Autorefraction - 6mm weak meridian (left) | Eyesight | UKBB00000079 | 30.98 |
| 52 | Waist-to-Hip ratio | Body measurement | UKBB00000905 | 30.96 |
| 53 | Corneal resistance factor | GCST90100568 | 30.78 |
| 54 | Phenylalanine levels | GCST90243407 | 30.74 |
| 55 | EGFR/FAP ratio | GCST90314613 | 30.37 |
| 56 | TNXB levels | GCST90470930 | 30.26 |
| 57 | Pulse pressure | GCST90301702 | 29.97 |
| 58 | Ankle spacing width | Bone-densitometry of heel | UKBB00000035 | 29.90 |
| 59 | Waist-hip index | GCST012228 | 29.48 |
| 60 | Subclinical hyperthyroidism in pregnancy | GCST90435199 | 29.47 |
| 61 | aparc-DKTatlas rh area inferiorparietal | GCST90003271 | 29.43 |
| 62 | Corneal resistance factor (left) | Intraocular pressure | UKBB00000150 | 29.38 |
| 63 | Ventral hernia (PheCode 550.5) | GCST90476063 | 29.02 |
| 64 | Dupuytren's disease | GCST90301252 | 28.49 |
| 65 | Impedance of whole body (UKB data field 23106) | GCST90468173 | 28.04 |
| 66 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000714 | 27.90 |
| 67 | Waist-to-hip ratio adjusted for BMI | GCST012230 | 27.90 |
| 68 | Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heel | UKBB00000324 | 27.77 |
| 69 | Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heel | UKBB00000318 | 27.77 |
| 70 | Ribothymidine levels in chronic kidney disease | GCST90257554 | 27.58 |
| 71 | COL6A3/CST3 ratio | GCST90314174 | 27.48 |
| 72 | Heel bone mineral density (BMD) | Bone-densitometry of heel | UKBB00000315 | 27.45 |
| 73 | Inguinal hernia (PheCode 550.1) | GCST90476060 | 27.43 |
| 74 | Pelvic organ prolapse | GCST90102470 | 27.28 |
| 75 | IGFBP6/SMOC2 ratio | GCST90315138 | 27.27 |
| 76 | Pulse pressure | GCST90472783 | 27.22 |
| 77 | Operation code - inguinal/femoral hernia repair | Operations | UKBB00000561 | 27.16 |
| 78 | ROBO2/SCARF2 ratio | GCST90315784 | 27.07 |
| 79 | Prescriptions - prostaglandin analog | UKBB00000697 | 27.06 |
| 80 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000715 | 27.01 |
| 81 | Waist circumference adjusted for body mass index | GCST90302892 | 27.01 |
| 82 | Dermatochalasis (PheCode 374.6) | GCST90475894 | 26.80 |
| 83 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 90) | GCST90320909 | 26.78 |
| 84 | Corneal hysteresis (left) | Intraocular pressure | UKBB00000148 | 26.64 |
| 85 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000718 | 26.44 |
| 86 | COL6A3/SMOC2 ratio | GCST90314178 | 26.33 |
| 87 | Corneal resistance factor (right) | Intraocular pressure | UKBB00000151 | 26.28 |
| 88 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000719 | 25.99 |
| 89 | QC T1 inverse SNR | GCST90006348 | 25.96 |
| 90 | FGR levels | GCST90469236 | 25.93 |
| 91 | FAP levels | GCST90469189 | 25.85 |
| 92 | Fracture of forearm | GCST90281273 | 25.68 |
| 93 | CNTN1 levels | GCST90468803 | 25.37 |
| 94 | Corneal resistance factor | GCST90308682 | 25.23 |
| 95 | IDP T1 FAST ROIs R occ pole | GCST90002546 | 25.22 |
| 96 | Open-angle glaucoma (PheCode 365.1) | GCST90475872 | 25.05 |
| 97 | Eye conditions (confirmatory factor analysis Factor 25) | GCST90309359 | 25.01 |
| 98 | Corneal hysteresis (right) | Intraocular pressure | UKBB00000149 | 24.68 |
| 99 | DLK1/FAP ratio | GCST90314491 | 24.59 |
| 100 | Takes medication for Macular Degeneration? | GCST90475387 | 24.53 |
| 101 | Autorefraction - 3mm weak meridian (left) | Eyesight | UKBB00000069 | 24.36 |
| 102 | Autorefraction - 3mm strong meridian (left) | Eyesight | UKBB00000065 | 24.15 |
| 103 | Heel bone mineral density | GCST006288 | 24.10 |
| 104 | aparc-Desikan rh area inferiorparietal | GCST90003114 | 23.96 |
| 105 | VCAN levels | GCST90471032 | 23.91 |
| 106 | Pelvic width | GCST90448911 | 23.73 |
| 107 | Heel broadband ultrasound attenuation (right) | Bone-densitometry of heel | UKBB00000320 | 23.68 |
| 108 | Female genital prolapse | Noninflammatory disorders of female genital tract | UKBB00000244 | 23.68 |
| 109 | Fracture of forearm | FING00000554 | 23.60 |
| 110 | TNC/VCAM1 ratio | GCST90315927 | 23.45 |
| 111 | Waist-to-hip ratio adjusted for BMI | GCST90025996 | 23.42 |
| 112 | BOC levels | GCST90468458 | 23.40 |
| 113 | Autorefraction - 3mm weak meridian (right) | Eyesight | UKBB00000070 | 23.30 |
| 114 | COL4A1 levels | GCST90468818 | 23.04 |
| 115 | Autorefraction - 6mm weak meridian (right) | Eyesight | UKBB00000080 | 23.01 |
| 116 | CLMP/PIK3IP1 ratio | GCST90314134 | 22.89 |
| 117 | aseg global volume-ratio BrainSegVol-to-eTIV | GCST90002612 | 22.80 |
| 118 | Female genital prolapse | FING00000535 | 22.59 |
| 119 | Glaucoma | GCST90475869 | 22.51 |
| 120 | CD200R1 levels | GCST90468605 | 22.49 |
| 121 | Autorefraction - 3mm strong meridian (right) | Eyesight | UKBB00000066 | 22.47 |
| 122 | Subpubic angle | GCST90448908 | 22.45 |
| 123 | Scoliosis | FING00001281 | 22.33 |
| 124 | Macular degeneration | GCST90475386 | 22.19 |
| 125 | Autorefraction - 6mm asymmetry index (left) | Eyesight | UKBB00000073 | 22.00 |
| 126 | DTI autoptx FA str r tract | GCST90385136 | 21.91 |
| 127 | Autorefraction - 6mm strong meridian (right) | Eyesight | UKBB00000076 | 21.77 |
| 128 | Other mental disorders due to brain damage and dysfunction and to physical disease | FING00001072 | 21.76 |
| 129 | Pulse pressure | GCST90310296 | 21.67 |
| 130 | Primary open-angle glaucoma, strict | FING00001214 | 21.65 |
| 131 | EGFR levels | GCST90469085 | 21.64 |
| 132 | aparc-a2009s lh volume G-precentral | GCST90002953 | 21.61 |
| 133 | Umbilical hernia | digestive | UKBB00000880 | 21.61 |
| 134 | IDP dMRI ProbtrackX L3 unc l | GCST90004325 | 21.55 |
| 135 | aparc-a2009s lh volume S-central | GCST90002969 | 21.50 |
| 136 | Impedance of whole body | Impedance measures | UKBB00000360 | 21.39 |
| 137 | Macular degeneration, wet (PheCode 362.22) | GCST90475852 | 21.22 |
| 138 | ZNRF4 levels | GCST90471104 | 21.20 |
| 139 | Umbilical hernia | Hernia | UKBB00000881 | 21.15 |
| 140 | Diaphragmatic hernia (PheCode 550.2) | GCST90476061 | 21.15 |
| 141 | Prolapse of vaginal walls | genitourinary | UKBB00000712 | 21.13 |
| 142 | C21orf58 levels | GCST90618380 | 21.12 |
| 143 | TNC levels | GCST90470895 | 20.82 |
| 144 | aparc-a2009s rh volume S-central | GCST90003043 | 20.76 |
| 145 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000716 | 20.69 |
| 146 | Pelvic inlet width | GCST90448910 | 20.69 |
| 147 | aparc-pial rh area inferiorparietal | GCST90003181 | 20.66 |
| 148 | SCARA5 levels | GCST90470533 | 20.51 |
| 149 | REST UKBBICA NET100 1287 | GCST90387141 | 20.48 |
| 150 | COL6A3/COLEC12 ratio | GCST90314173 | 20.34 |
| 151 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000717 | 20.33 |
| 152 | Appendicular lean mass | GCST90000027 | 20.32 |
| 153 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000720 | 20.13 |
| 154 | IDP dMRI ProbtrackX MD unc l | GCST90004244 | 20.03 |
| 155 | Forced expiratory volume in 1-second (FEV1), predicted | Spirometry | UKBB00000252 | 19.93 |
| 156 | Haemorrhoidal disease | GCST90014033 | 19.93 |
| 157 | Genital prolapse | genitourinary | UKBB00000282 | 19.85 |
| 158 | Glaucoma (multi-trait analysis) | GCST009722 | 19.65 |
| 159 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000721 | 19.61 |
| 160 | Intraocular pressure | GCST004074 | 19.59 |
| 161 | Autorefraction - 3mm strong meridian angle (left) | Eyesight | UKBB00000067 | 19.41 |
| 162 | RET levels | GCST90470458 | 19.38 |
| 163 | Retinal breaks without detachment | FING00001258 | 19.33 |
| 164 | Impedance of leg (right) | Impedance measures | UKBB00000359 | 19.31 |
| 165 | Lymphoplasmacytic lymphoma and Waldenstrom macroglobulinemia | GCST90624744 | 19.23 |
| 166 | Hallux valgus (Bunion) (PheCode 735.3) | GCST90476251 | 19.20 |
| 167 | Alzheimer's disease (MTAG) | GCST90449055 | 19.19 |
| 168 | ENG levels | GCST90469108 | 19.13 |
| 169 | Diaphragmatic hernia | FING00000419 | 19.07 |
| 170 | Descending aorta diameter | GCST90267391 | 18.90 |
| 171 | CTSD/PRCP ratio | GCST90314312 | 18.89 |
| 172 | HSPG2/SMOC2 ratio | GCST90315093 | 18.81 |
| 173 | RFC4 levels | GCST90470460 | 18.60 |
| 174 | Hip circumference adjusted for BMI | GCST90020028 | 18.59 |
| 175 | Macular degeneration (senile) of retina NOS (PheCode 362.29) | GCST90475857 | 18.53 |
| 176 | LGALS3 levels | GCST90469761 | 18.52 |
| 177 | Impedance of leg (left) | Impedance measures | UKBB00000358 | 18.51 |
| 178 | Hereditary deficiency of other clotting factors | FING00000612 | 18.48 |
| 179 | BCL2 levels | GCST90468433 | 18.47 |
| 180 | Iliac isthmus breadth | GCST90448907 | 18.39 |
| 181 | BA-exvivo lh area entorhinal | GCST90003220 | 18.37 |
| 182 | Volume of left paralaminar nucleus | GCST90474982 | 18.25 |
| 183 | Haemorrhoids and perianal venous thrombosis | FING00000599 | 18.16 |
| 184 | IDP dMRI TBSS L2 Sagittal stratum L | GCST90004154 | 18.14 |
| 185 | BA-exvivo lh volume BA3a | GCST90002837 | 18.05 |
| 186 | IDP T1 FAST ROIs V cerebellum VIIIa | GCST90002579 | 17.97 |
| 187 | Glaucoma suspect | FING00000579 | 17.94 |
| 188 | MAMDC2 levels | GCST90469841 | 17.88 |
| 189 | Lung function (FVC) | GCST007429 | 17.86 |
| 190 | IDP dMRI TBSS L1 External capsule L | GCST90004108 | 17.81 |
| 191 | Deforming dorsopathies | FING00000385 | 17.73 |
| 192 | SLITRK6 levels | GCST90470671 | 17.71 |
| 193 | Umbilical hernia (PheCode 550.4) | GCST90476062 | 17.60 |
| 194 | Pulse pressure | GCST90472784 | 17.59 |
| 195 | Disorders of choroid and retina | FING00000438 | 17.59 |
| 196 | ERBB3 levels | GCST90469140 | 17.52 |
| 197 | CASP1 levels | GCST90468543 | 17.50 |
| 198 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3 | ECGU000003 | 17.44 |
| 199 | Primary open angle glaucoma (PheCode 365.11) | GCST90475875 | 17.41 |
| 200 | Tibia length to body height ratio | GCST90270258 | 17.41 |
| 201 | IDP dMRI TBSS MD External capsule L | GCST90004060 | 17.36 |
| 202 | Calcific aortic valve stenosis | GCST90310293 | 17.32 |
| 203 | AOC3 levels | GCST90468322 | 17.19 |
| 204 | COL6A3/OGN ratio | GCST90314177 | 17.05 |
| 205 | Height | GCST90278637 | 17.00 |
| 206 | IDP dMRI ProbtrackX MO str r | GCST90004024 | 16.98 |
| 207 | IDP dMRI ProbtrackX L3 unc r | GCST90004326 | 16.98 |
| 208 | DTI autoptx L3 str r tract | GCST90385217 | 16.97 |
| 209 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5 | ECGU000005 | 16.93 |
| 210 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4 | ECGU000004 | 16.88 |
| 211 | Forced vital capacity (FVC) | Spirometry | UKBB00000254 | 16.88 |
| 212 | Coronary artery calcification | GCST90278456 | 16.85 |
| 213 | Incisional hernia (PheCode 550.6) | GCST90476064 | 16.71 |
| 214 | Free testosterone levels | GCST90239826 | 16.53 |
| 215 | Mean volume of bilateral amygdala | GCST90474994 | 16.23 |
| 216 | Undecenoylcarnitine (C11:1) levels | GCST90200236 | 16.15 |
| 217 | Diverticular disease of intestine | Other diseases of intestines | UKBB00000189 | 16.08 |
| 218 | aparc-Desikan lh volume precentral | GCST90002791 | 16.08 |
| 219 | Height | GCST90018739 | 15.99 |
| 220 | Ankle spacing width (right) | Bone-densitometry of heel | UKBB00000034 | 15.95 |
| 221 | Volume of right accessory basal nucleus | GCST90475006 | 15.91 |
| 222 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320620 | 15.91 |
| 223 | Illnesses of father - Heart disease | Family history | UKBB00000342 | 15.88 |
| 224 | Maximum carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000429 | 15.86 |
| 225 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 123) | GCST90320686 | 15.83 |
| 226 | Volume of left basal nucleus | GCST90474946 | 15.81 |
| 227 | CDON/SCARA5 ratio | GCST90313995 | 15.77 |
| 228 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T9 | ECGU000009 | 15.65 |
| 229 | Pelvic height | GCST90448912 | 15.54 |
| 230 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T8 | ECGU000008 | 15.50 |
| 231 | Maximum indexed left atrial volume | GCST90019012 | 15.43 |
| 232 | Takes medication for Glaucoma? | GCST90475384 | 15.42 |
| 233 | Retinal thickness (functional principal component 2) | GCST90455722 | 15.40 |
| 234 | Appendicular lean mass | GCST90000025 | 15.35 |
| 235 | BPIFB1/GLRX ratio | GCST90313530 | 15.32 |
| 236 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2 | ECGU000002 | 15.31 |
| 237 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 82) | GCST90320645 | 15.25 |
| 238 | Waist circumference adjusted for body mass index | GCST012226 | 15.25 |
| 239 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 15.25 |
| 240 | CCN3/FAP ratio | GCST90313721 | 15.20 |
| 241 | CXCL10/WARS ratio | GCST90314332 | 15.20 |
| 242 | Hypertrophy of breast | FING00000644 | 15.20 |
| 243 | Diverticulosis and diverticulitis | digestive | UKBB00000191 | 15.18 |
| 244 | DTI autoptx L2 str r tract | GCST90385190 | 15.14 |
| 245 | Forearm length to body height ratio | GCST90270257 | 15.13 |
| 246 | Appendicular lean mass | GCST90000026 | 15.11 |
| 247 | Forced vital capacity FVC Z score (UKB data field 20257) | GCST90468167 | 15.05 |
| 248 | Tetradecadienedioate (C14:2-DC) metabolite level | GCST90616275 | 15.03 |
| 249 | Diverticulosis | digestive | UKBB00000190 | 14.97 |
| 250 | HRC levels | GCST90469475 | 14.96 |
| 251 | SRPX levels | GCST90470744 | 14.94 |
| 252 | Ankle spacing width (left) | Bone-densitometry of heel | UKBB00000033 | 14.92 |
| 253 | C7 levels | GCST90422332 | 14.89 |
| 254 | diastolic blood pressure (DBP, mean, inv-normal transformed) | GCST90475255 | 14.82 |
| 255 | Pulse pressure (BMI adjusted) | GCST90335167 | 14.82 |
| 256 | Keloid | GCST90652488 | 14.79 |
| 257 | COMP/DPP4 ratio | GCST90314188 | 14.72 |
| 258 | Glaucoma (primary open-angle) | GCST90399725 | 14.71 |
| 259 | BA-exvivo lh volume entorhinal | GCST90002848 | 14.68 |
| 260 | HEG1 levels | GCST90469444 | 14.62 |
| 261 | EIF4G1/TBC1D23 ratio | GCST90314639 | 14.60 |
| 262 | VWF levels | GCST90471065 | 14.60 |
| 263 | Volume of right basal nucleus | GCST90475012 | 14.56 |
| 264 | FOLH1 levels | GCST90427192 | 14.54 |
| 265 | BCAN/DPP6 ratio | GCST90313478 | 14.44 |
| 266 | Sitting height | Body size measures | UKBB00000771 | 14.40 |
| 267 | Diverticulosis (PheCode 562.1) | GCST90476076 | 14.38 |
| 268 | Angina pectoris | GCST90018573 | 14.37 |
| 269 | Progressive vascular leukoencephalopathy | FING00001218 | 14.27 |
| 270 | aparc-DKTatlas lh volume precentral | GCST90002884 | 14.26 |
| 271 | Operative procedures - Haemorrhoidectomy | Summary Operations | UKBB00000580 | 14.24 |
| 272 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6 | ECGU000006 | 14.18 |
| 273 | Synovitis and tenosynovitis (PheCode 727.1) | GCST90476242 | 14.16 |
| 274 | Bone density T-score | GCST90278620 | 14.10 |
| 275 | Barrett's esophagus (PheCode 530.13) | GCST90476048 | 14.08 |
| 276 | Other aneurysm (PheCode 442) | GCST90475992 | 14.05 |
| 277 | EFEMP1/FSTL3 ratio | GCST90314595 | 14.05 |
| 278 | Blood cell traits latent factor 21 (red cell) | GCST90559263 | 14.04 |
| 279 | Hand grip strength right (UKB data field 47) | GCST90468169 | 14.03 |
| 280 | POSTN levels | GCST90470288 | 13.91 |
| 281 | Cerebrospinal fluid unidentified metabolite levels (HILIC Metabolomics ID: 3.04_132.06) | GCST90291582 | 13.87 |
| 282 | BA-exvivo rh volume BA3a | GCST90002851 | 13.85 |
| 283 | Operation code - haemorroidectomy / piles surgery/ banding of piles | Operations | UKBB00000557 | 13.84 |
| 284 | Diaphragmatic hernia | digestive | UKBB00000171 | 13.81 |
| 285 | Operative procedures - Angiocardiography of left side of heart NEC | Summary Operations | UKBB00000572 | 13.79 |
| 286 | height (mean, inv-normal transformed) | GCST90475362 | 13.74 |
| 287 | PTPRF/PTPRS ratio | GCST90315751 | 13.72 |
| 288 | SIL1 levels | GCST90470638 | 13.68 |
| 289 | Volume of right lateral nucleus | GCST90475034 | 13.68 |
| 290 | IDP dMRI ProbtrackX L2 unc l | GCST90004298 | 13.64 |
| 291 | Autorefraction - 6mm strong meridian angle (right) | Eyesight | UKBB00000078 | 13.61 |
| 292 | IDP dMRI ProbtrackX MD unc r | GCST90004245 | 13.58 |
| 293 | Height (maximum, inv-normal transformed) | GCST90475359 | 13.55 |
| 294 | PILRA/TNFRSF1A ratio | GCST90315655 | 13.54 |
| 295 | Hand grip strength left (UKB data field 46) | GCST90468168 | 13.51 |
| 296 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 37) | GCST90320856 | 13.51 |
| 297 | Aortic aneurysm (PheCode 442.1) | GCST90475993 | 13.49 |
| 298 | Calcific aortic valvular stenosis, operated | FING00000234 | 13.47 |
| 299 | ALB levels | GCST90475103 | 13.42 |
| 300 | IDP dMRI ProbtrackX L2 ilf l | GCST90004287 | 13.36 |
| 301 | Volume of right cortico-amygdaloid transition area | GCST90475018 | 13.35 |
| 302 | Valine levels | GCST90243453 | 13.31 |
| 303 | Glaucoma (primary open-angle) | GCST90011768 | 13.28 |
| 304 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7 | ECGU000007 | 13.27 |
| 305 | CD34 levels | GCST90468626 | 13.26 |
| 306 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320887 | 13.21 |
| 307 | Bone density Z-score | GCST90278621 | 13.18 |
| 308 | Right-hemisphere visual network to right-hemisphere control network white-matter structural connectivity | GCST90302779 | 13.16 |
| 309 | X-17676 levels | GCST90200548 | 13.12 |
| 310 | ADGRD1 levels | GCST90468235 | 13.12 |
| 311 | PSPN levels | GCST90470364 | 13.09 |
| 312 | Treatment speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000835 | 13.08 |
| 313 | Nerve, nerve root and plexus disorders | FING00000862 | 13.07 |
| 314 | height (minimum, inv-normal transformed) | GCST90475365 | 13.06 |
| 315 | aseg global volume WM-hypointensities | GCST90002604 | 13.05 |
| 316 | IDP dMRI ProbtrackX FA ilf l | GCST90003939 | 13.00 |
| 317 | CDON levels | GCST90468687 | 13.00 |
| 318 | PON1 levels | GCST90470285 | 12.99 |
| 319 | MATN2 levels | GCST90469864 | 12.98 |
| 320 | MCEE levels | GCST90469871 | 12.93 |
| 321 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 59) | GCST90320878 | 12.88 |
| 322 | T1 FreeSurfer DKT rh fusiform thickness | GCST90384322 | 12.80 |
| 323 | Hand grip strength (right) | Hand grip strength | UKBB00000301 | 12.77 |
| 324 | Peritonsillar abscess | FING00001160 | 12.76 |
| 325 | ST6GALNAC2 levels | GCST90240251 | 12.74 |
| 326 | BA-exvivo rh volume BA4p | GCST90002854 | 12.67 |
| 327 | LTBP2 levels | GCST90469814 | 12.63 |
| 328 | ADAMTS8 levels | GCST90468227 | 12.60 |
| 329 | Urine glucuronide of C10H18O2 (12)* levels in chronic kidney disease | GCST90265189 | 12.57 |
| 330 | Autorefraction - 3mm cylindrical power (left) | Eyesight | UKBB00000062 | 12.56 |
| 331 | Nonrheumatic aortic valve disorders (PheCode 395.2) | GCST90475914 | 12.53 |
| 332 | CD69/CDKN2D ratio | GCST90313866 | 12.49 |
| 333 | Lung cancer | GCST90011812 | 12.49 |
| 334 | Fractures | GCST006980 | 12.47 |
| 335 | Glaucoma | GCST90475383 | 12.32 |
| 336 | FUT8/TNFSF14 ratio | GCST90314895 | 12.29 |
| 337 | Systolic blood pressure | GCST90301697 | 12.24 |
| 338 | Age-related eyesight deterioration (confirmatory factor analysis Factor 27) | GCST90309361 | 12.21 |
| 339 | DNAJA2/PLXNA4 ratio | GCST90314504 | 12.18 |
| 340 | DTI autoptx MD unc l tract | GCST90385245 | 12.15 |
| 341 | PRELP levels | GCST90470321 | 12.11 |
| 342 | Operative procedures - Insertion of prosthetic replacement for lens NEC | Summary Operations | UKBB00000583 | 12.10 |
| 343 | Kyphosis (MTAG) | GCST90570047 | 12.10 |
| 344 | ALB levels | GCST90475106 | 12.05 |
| 345 | TNN levels | GCST90470927 | 12.04 |
| 346 | Triglyceride to HDL cholesterol ratio | GCST90295951 | 12.00 |
| 347 | CCDC80/CCL27 ratio | GCST90313669 | 11.99 |
| 348 | What is your height? (cm, inv-normal transformed) | GCST90475368 | 11.99 |
| 349 | Fractured/broken bones in last 5 years | Medical conditions | UKBB00000258 | 11.98 |
| 350 | PLXDC2 levels | GCST90470264 | 11.98 |
| 351 | Pulse pressure (BMI unadjusted) | GCST90335166 | 11.98 |
| 352 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 40) | GCST90320859 | 11.96 |
| 353 | Hereditary corneal dystrophies | FING00000611 | 11.93 |
| 354 | CTSO/IGF2R ratio | GCST90314317 | 11.93 |
| 355 | COLEC12/TGFBR2 ratio | GCST90314186 | 11.89 |
| 356 | Abdominal aortic aneurysm (PheCode 442.11) | GCST90475994 | 11.88 |
| 357 | Umbilical hernia | FING00001395 | 11.86 |
| 358 | Sleep apnea (MTAG) (adjusted for BMI) | GCST90267364 | 11.85 |
| 359 | Volume of right basal nucleus | GCST90474910 | 11.84 |
| 360 | Hip circumference adjusted for BMI | GCST012227 | 11.82 |
| 361 | Depression/anxiety (weighted GWA) | GCST90267277 | 11.81 |
| 362 | Cereal type - Oat cereal (e.g. Ready Brek, porridge) | Diet | UKBB00000124 | 11.80 |
| 363 | Intra-ocular pressure, corneal-compensated (left) | Intraocular pressure | UKBB00000374 | 11.78 |
| 364 | COMP/MYOC ratio | GCST90314191 | 11.76 |
| 365 | Tonsillectomy and adenotomy | FING00001367 | 11.76 |
| 366 | A body shape index | GCST012231 | 11.76 |
| 367 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1 | ECGU000001 | 11.76 |
| 368 | BTN2A1/SMOC2 ratio | GCST90313549 | 11.74 |
| 369 | Perforation of tympanic membrane | FING00001155 | 11.67 |
| 370 | Other joint disorders | FING00001064 | 11.65 |
| 371 | Seated height | Body size measures | UKBB00000763 | 11.65 |
| 372 | PAMR1 levels | GCST90470155 | 11.57 |
| 373 | aparc-DKTatlas lh area entorhinal | GCST90003238 | 11.55 |
| 374 | Femur length to body height ratio | GCST90270256 | 11.55 |
| 375 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 24) | GCST90320587 | 11.54 |
| 376 | IDP dMRI ProbtrackX L2 unc r | GCST90004299 | 11.54 |
| 377 | aparc-a2009s lh area S-collat-transv-ant | GCST90003346 | 11.54 |
| 378 | EFEMP1/TGFBR3 ratio | GCST90314597 | 11.49 |
| 379 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007526 | 11.49 |
| 380 | DTI TBSS L3 Retrolenticular part of internal capsule L | GCST90384545 | 11.48 |
| 381 | MXRA8 levels | GCST90469968 | 11.41 |
| 382 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 75) | GCST90320894 | 11.39 |
| 383 | Volume of left whole amygdala | GCST90474988 | 11.33 |
| 384 | INHBC levels | GCST90469615 | 11.33 |
| 385 | ADAMTSL2 levels | GCST90468228 | 11.33 |
| 386 | Osteopenia or other disorder of bone and cartilage (PheCode 743.9) | GCST90476261 | 11.31 |
| 387 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 11.30 |
| 388 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432179 | 11.30 |
| 389 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 77) | GCST90320896 | 11.30 |
| 390 | Operative procedures - Anastomosis of mammary artery to left anterior descending coronary artery | Summary Operations | UKBB00000571 | 11.29 |
| 391 | IDP dMRI ProbtrackX MD cgh l | GCST90004225 | 11.29 |
| 392 | Use of antiglaucoma preparations and miotics | FING00001409 | 11.26 |
| 393 | ICD10 N81: Female genital prolapse | GCST90454214 | 11.25 |
| 394 | IGF1 levels | GCST90025989 | 11.22 |
| 395 | Intra-ocular pressure, corneal-compensated (right) | Intraocular pressure | UKBB00000375 | 11.21 |
| 396 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 68) | GCST90320631 | 11.14 |
| 397 | Glaucoma | FING00000577 | 11.13 |
| 398 | BA-exvivo lh thickness BA4a | GCST90003517 | 11.09 |
| 399 | Glaucoma | GCST90018632 | 11.09 |
| 400 | HSPG2 levels | GCST90179392 | 11.06 |
| 401 | FCRL2/TNFRSF13B ratio | GCST90314801 | 11.05 |
| 402 | Prescriptions - losartan | angiotensin receptor blocker,anti-hypertensive,ARB | UKBB00000690 | 11.03 |
| 403 | Free androgen index | GCST90239824 | 11.01 |
| 404 | aparc-a2009s rh volume G-front-inf-Triangul | GCST90003012 | 10.99 |
| 405 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 39) | GCST90320858 | 10.98 |
| 406 | Thoracic aortic aneurysm | FING00001357 | 10.96 |
| 407 | MSMB levels | GCST90469949 | 10.95 |
| 408 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 91) | GCST90320654 | 10.91 |
| 409 | Intestinal infectious diseases | FING00000689 | 10.89 |
| 410 | Intracerebral hemorrhage | GCST90018650 | 10.83 |
| 411 | PON3 levels | GCST90470287 | 10.81 |
| 412 | Systolic blood pressure (weighted GWA) | GCST90267305 | 10.81 |
| 413 | GAPDH levels | GCST90469302 | 10.79 |
| 414 | COL6A3/HSPG2 ratio | GCST90314175 | 10.79 |
| 415 | Aortic aneurysm | FING00000102 | 10.78 |
| 416 | Phosphatidylcholine-O_34:3_[M+H]1+/Phosphatidylcholine-P_34:2_[M+H]1+/Phosphatidylethanolamine-P_37:2_[M+H]1+ levels | GCST90060277 | 10.77 |
| 417 | Glaucoma (primary open-angle) | GCST90011766 | 10.77 |
| 418 | COLEC12/OGN ratio | GCST90314184 | 10.77 |
| 419 | aseg global volume EstimatedTotalIntraCranial | GCST90002597 | 10.76 |
| 420 | Total protein levels | GCST90025995 | 10.74 |
| 421 | DPP6/SEZ6L ratio | GCST90314544 | 10.67 |
| 422 | ITGA11 levels | GCST90469633 | 10.66 |
| 423 | Coronary artery plaque burden | GCST90503075 | 10.61 |
| 424 | Illnesses of mother - None of the above (group 1) | Family history | UKBB00000349 | 10.61 |
| 425 | Drusen (degenerative) of retina (PheCode 362.27) | GCST90475855 | 10.57 |
| 426 | Trunk fat percentage | Impedance measures | UKBB00000864 | 10.57 |
| 427 | Contracture of palmar fascia [Dupuytren's disease] | musculoskeletal | UKBB00000146 | 10.55 |
| 428 | QC rfMRI-to-T1 linear alignment discrepancy | GCST90006353 | 10.53 |
| 429 | Inguinal hernia, bilateral | FING00000682 | 10.50 |
| 430 | Medication use (antithrombotic agents) | GCST90018762 | 10.49 |
| 431 | Height | GCST90302890 | 10.45 |
| 432 | ADGRB3 levels | GCST90468234 | 10.43 |
| 433 | AGRN/HSPG2 ratio | GCST90313201 | 10.43 |
| 434 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320845 | 10.43 |
| 435 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 46) | GCST90320609 | 10.40 |
| 436 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 10.39 |
| 437 | Myopia (PheCode 367.1) | GCST90475880 | 10.38 |
| 438 | CHRDL1/SMOC2 ratio | GCST90314062 | 10.38 |
| 439 | Disorders of muscle, ligament, and fascia | musculoskeletal | UKBB00000187 | 10.36 |
| 440 | ASPN levels | GCST90468377 | 10.36 |
| 441 | Blepharochalasis | FING00000220 | 10.35 |
| 442 | CCN3 levels | GCST90468589 | 10.31 |
| 443 | NPL levels | GCST90470072 | 10.28 |
| 444 | Gestational age at birth (child effect) | GCST90268421 | 10.27 |
| 445 | Operation code - carpal tunnel surgery | Operations | UKBB00000553 | 10.27 |
| 446 | Anterior thigh muscle fat infiltration percentage | GCST90267351 | 10.26 |
| 447 | SSC5D levels | GCST90470748 | 10.26 |
| 448 | Standing height | Body size measures | UKBB00000796 | 10.24 |
| 449 | PTPRH levels | GCST90470382 | 10.22 |
| 450 | Body size (confirmatory factor analysis Factor 21) | GCST90309355 | 10.21 |
| 451 | MFAP4 levels | GCST90469898 | 10.16 |
| 452 | Ventral hernia | FING00001428 | 10.15 |
| 453 | IDP dMRI TBSS L3 External capsule L | GCST90004204 | 10.13 |
| 454 | aparc-a2009s lh thickness G-cuneus | GCST90003613 | 10.11 |
| 455 | VIT levels | GCST90471041 | 10.11 |
| 456 | PATE4 levels | GCST90242405 | 10.10 |
| 457 | 1-palmitoyl-2-arachidonoyl-gpc (16:0/20:4n6) levels | GCST90200692 | 10.10 |
| 458 | Hand grip strength (left) | Hand grip strength | UKBB00000300 | 10.09 |
| 459 | Liver proton density fat fraction | GCST90267352 | 10.09 |
| 460 | Volume of right whole amygdala | GCST90475054 | 10.08 |
| 461 | IGF1 levels | GCST90468078 | 10.06 |
| 462 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 127) | GCST90320690 | 10.06 |
| 463 | Operative procedures - Palmar fasciectomy | Summary Operations | UKBB00000586 | 10.03 |
| 464 | aparc-a2009s lh thickness G-postcentral | GCST90003630 | 10.02 |
| 465 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320940 | 10.00 |
| 466 | Coronary angioplasty | FING00000357 | 9.96 |
| 467 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 47) | GCST90320866 | 9.96 |
| 468 | Diacylglycerol_38:5_[M+H-H2O]1+ levels | GCST90060200 | 9.94 |
| 469 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 54) | GCST90320873 | 9.93 |
| 470 | ALB levels | GCST90475100 | 9.89 |
| 471 | Cerebrospinal fluid 3-hydroxyhexanoate levels | GCST90318108 | 9.87 |
| 472 | ITGBL1 levels | GCST90469648 | 9.84 |
| 473 | Coronary atherosclerosis (PheCode 411.4) | GCST90043957 | 9.79 |
| 474 | DLK1/PIK3IP1 ratio | GCST90314492 | 9.79 |
| 475 | Unstable angina pectoris | FING00001405 | 9.79 |
| 476 | PSAP levels | GCST90426586 | 9.79 |
| 477 | APOF levels | GCST90468339 | 9.78 |
| 478 | IDP dMRI TBSS MD Cingulum cingulate gyrus L | GCST90004062 | 9.78 |
| 479 | Biological Sibling: Alzheimer's / Other Dementia | GCST90476375 | 9.76 |
| 480 | COL6A3/TAFA5 ratio | GCST90314180 | 9.75 |
| 481 | Hypertrophy of breast in women and men | FING00000645 | 9.72 |
| 482 | FUS levels | GCST90469278 | 9.72 |
| 483 | SFRP2 levels | GCST90242727 | 9.71 |
| 484 | PTPRZ1 levels | GCST90470388 | 9.71 |
| 485 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 64) | GCST90320883 | 9.68 |
| 486 | DTI TBSS MD Retrolenticular part of internal capsule L | GCST90384593 | 9.65 |
| 487 | IDP dMRI TBSS L3 External capsule R | GCST90004203 | 9.54 |
| 488 | Hand grip strength (baseline) | GCST90565845 | 9.53 |
| 489 | IDP dMRI ProbtrackX L3 ifo r | GCST90004313 | 9.50 |
| 490 | Retinal arteriolar width | GCST90270398 | 9.49 |
| 491 | Acquired foot deformities (PheCode 735) | GCST90476247 | 9.49 |
| 492 | IDP T1 FAST ROIs L caudate | GCST90002549 | 9.48 |
| 493 | IDP dMRI ProbtrackX FA unc r | GCST90003951 | 9.47 |
| 494 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 57) | GCST90320876 | 9.45 |
| 495 | Palmar fascial fibromatosis [Dupuytren] | FING00001141 | 9.44 |
| 496 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 122) | GCST90320941 | 9.44 |
| 497 | NPY/SMOC1 ratio | GCST90315551 | 9.42 |
| 498 | Benign mammary dysplasia | FING00000151 | 9.41 |
| 499 | Osteoporosis | GCST90468145 | 9.41 |
| 500 | aparc-Desikan lh thickness postcentral | GCST90003466 | 9.37 |
| 501 | GSTA4 levels | GCST90241283 | 9.34 |
| 502 | CD59/SCARB2 ratio | GCST90313859 | 9.33 |
| 503 | Medication use (salicylic acid and derivatives) | GCST90018775 | 9.31 |
| 504 | wg lh intensity-contrast middletemporal | GCST90003806 | 9.31 |
| 505 | Anterior thigh muscle volume | GCST90267349 | 9.30 |
| 506 | CST3/TFF3 ratio | GCST90314299 | 9.28 |
| 507 | ESR1 levels | GCST90469155 | 9.27 |
| 508 | BA-exvivo lh volume BA4p | GCST90002840 | 9.21 |
| 509 | Standing height (UKB data field 50) | GCST90468178 | 9.20 |
| 510 | SERPING1 levels | GCST90470600 | 9.19 |
| 511 | Macular degeneration, dry (PheCode 362.21) | GCST90475851 | 9.18 |
| 512 | Carotid intima-media thickness (MTAG) | GCST90449061 | 9.15 |
| 513 | IDP dMRI TBSS OD Fornix | GCST90004407 | 9.15 |
| 514 | QC T1-to-standard nonlinear alignment discrepancy | GCST90006346 | 9.14 |
| 515 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 114) | GCST90320677 | 9.12 |
| 516 | Systolic blood pressure | GCST90472782 | 9.12 |
| 517 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 126) | GCST90320689 | 9.10 |
| 518 | Autorefraction - 3mm cylindrical power (right) | Eyesight | UKBB00000063 | 9.09 |
| 519 | ITGB1 levels | GCST90469643 | 9.09 |
| 520 | DPP6/SEZ6L2 ratio | GCST90314543 | 9.07 |
| 521 | Coronary artery calcification | GCST90503074 | 9.06 |
| 522 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320604 | 9.06 |
| 523 | Height, inverse-rank normalized | FING00000607 | 9.05 |
| 524 | IDP dMRI ProbtrackX L3 ilf l | GCST90004314 | 9.04 |
| 525 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 76) | GCST90320895 | 9.03 |
| 526 | HGF/TNFSF14 ratio | GCST90315060 | 9.02 |
| 527 | DTI TBSS L3 Superior corona radiata L | GCST90384549 | 9.01 |
| 528 | Other menopausal disorders | FING00001071 | 9.00 |
| 529 | NRP1 levels | GCST90470085 | 9.00 |
| 530 | FST levels | GCST90469273 | 9.00 |
| 531 | Corneal opacity and other disorders of cornea (PheCode 364) | GCST90475861 | 8.97 |
| 532 | Descending aorta distensibility | GCST90267386 | 8.95 |
| 533 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 51) | GCST90320614 | 8.95 |
| 534 | IDP dMRI TBSS L1 External capsule R | GCST90004107 | 8.93 |
| 535 | OMD levels | GCST90470123 | 8.93 |
| 536 | IDP dMRI TBSS MD External capsule R | GCST90004059 | 8.91 |
| 537 | DKKL1 levels | GCST90469000 | 8.91 |
| 538 | aparc-DKTatlas lh thickness cuneus | GCST90003543 | 8.90 |
| 539 | PLXDC1 levels | GCST90470263 | 8.89 |
| 540 | NOTCH3/PTPRS ratio | GCST90315547 | 8.89 |
| 541 | Diacylglycerol (18:0_18:1) levels | GCST90024714 | 8.89 |
| 542 | Other hammer toe(s) (acquired) | FING00001054 | 8.84 |
| 543 | Hernia of abdominal wall | FING00000617 | 8.82 |
| 544 | LAMP1 levels | GCST90469733 | 8.82 |
| 545 | BA-exvivo rh volume BA3b | GCST90002852 | 8.82 |
| 546 | Total thigh muscle volume z-score | GCST90267356 | 8.80 |
| 547 | TNFRSF14/TNFSF14 ratio | GCST90315936 | 8.80 |
| 548 | IDP dMRI TBSS L2 Retrolenticular part of internal capsule L | GCST90004144 | 8.78 |
| 549 | ALKBH3 levels | GCST90619095 | 8.78 |
| 550 | aparc-Desikan rh thickness paracentral | GCST90003495 | 8.77 |
| 551 | ENPP7 levels | GCST90469118 | 8.77 |
| 552 | Diaphragmatic hernia | Hernia | UKBB00000172 | 8.76 |
| 553 | CD109 levels | GCST90468597 | 8.76 |
| 554 | aparc-DKTatlas rh volume parstriangularis | GCST90002911 | 8.74 |
| 555 | Takes medication for heart attack? | GCST90475212 | 8.73 |
| 556 | ITGAM/ITGAV ratio | GCST90315209 | 8.71 |
| 557 | systolic blood pressure (SBP, mean, inv-normal transformed) | GCST90476403 | 8.71 |
| 558 | GGH/INHBC ratio | GCST90314928 | 8.69 |
| 559 | IGF1 levels | UKBB00000337 | 8.68 |
| 560 | Phosphatidylcholine_34:2_[M+H]1+/Phosphatidylethanolamine_37:2_[M+H]1+/Phosphatidate_39:3_[M+NH4]1+ levels | GCST90060303 | 8.67 |
| 561 | wg rh intensity-contrast caudalmiddlefrontal | GCST90003830 | 8.66 |
| 562 | aparc-DKTatlas lh thickness postcentral | GCST90003560 | 8.64 |
| 563 | CFHR4 levels | GCST90019045 | 8.64 |
| 564 | Stable angina pectoris | GCST90018695 | 8.64 |
| 565 | Osteoarthrosis | musculoskeletal | UKBB00000596 | 8.62 |
| 566 | OLR1 levels | GCST90012020 | 8.61 |
| 567 | Operation code - varicose vein surgery | Operations | UKBB00000568 | 8.61 |
| 568 | wg lh intensity-contrast transversetemporal | GCST90003825 | 8.60 |
| 569 | Operation code - inguinal hernia repair | Operations | UKBB00000560 | 8.58 |
| 570 | Levulinate 4-oxovalerate levels | GCST90243545 | 8.57 |
| 571 | Spontaneous coronary artery dissection | GCST90245878 | 8.57 |
| 572 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 60) | GCST90320623 | 8.55 |
| 573 | Heart rate variability traits (SDNN) | GCST004734 | 8.55 |
| 574 | Left hippocampal volume (tail) | GCST90267951 | 8.54 |
| 575 | IDP dMRI ProbtrackX MD ilf l | GCST90004233 | 8.53 |
| 576 | Snoring | GCST009761 | 8.53 |
| 577 | CNTN4 levels | GCST90468806 | 8.50 |
| 578 | CCDC80/CHRDL1 ratio | GCST90313670 | 8.49 |
| 579 | ICAM2 levels | GCST90469499 | 8.46 |
| 580 | DPP6 levels | GCST90469034 | 8.46 |
| 581 | RBP5 levels | GCST90470439 | 8.45 |
| 582 | Olsenella C abundance in stool | GCST90032493 | 8.45 |
| 583 | Height (baseline) | GCST90565843 | 8.42 |
| 584 | CD164/PARK7 ratio | GCST90313743 | 8.41 |
| 585 | Testosterone levels | GCST90483486 | 8.40 |
| 586 | APP/FKBP1B ratio | GCST90313323 | 8.39 |
| 587 | ANGPTL7 levels | GCST90468306 | 8.38 |
| 588 | Mean carotid IMT (intima-medial thickness) at 240 degrees | Carotid ultrasound | UKBB00000446 | 8.36 |
| 589 | aparc-Desikan rh volume parahippocampal | GCST90002816 | 8.36 |
| 590 | Degeneration of macula and posterior pole of retina (PheCode 362.2) | GCST90475849 | 8.35 |
| 591 | Mean carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000445 | 8.35 |
| 592 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58) | GCST90320621 | 8.34 |
| 593 | SCAMP3/VPS53 ratio | GCST90315807 | 8.34 |
| 594 | Main speciality of consultant (recoded) - Ophthalmology | Summary Administration | UKBB00000419 | 8.34 |
| 595 | FST/FSTL3 ratio | GCST90314882 | 8.33 |
| 596 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 115) | GCST90320678 | 8.32 |
| 597 | aparc-DKTatlas rh thickness paracentral | GCST90003586 | 8.31 |
| 598 | Comparative height size at age 10 | Early life factors | UKBB00000143 | 8.31 |
| 599 | IDP dMRI TBSS L1 Fornix | GCST90004080 | 8.31 |
| 600 | aparc-Desikan lh thickness cuneus | GCST90003449 | 8.30 |
| 601 | Osteoporosis | musculoskeletal | UKBB00000598 | 8.29 |
| 602 | HHIP levels | GCST90617097 | 8.29 |
| 603 | Volume of right accessory basal nucleus | GCST90474907 | 8.28 |
| 604 | VSNL1 levels | GCST90471054 | 8.27 |
| 605 | Coronary revascularization (ANGIO or CABG) | FING00000360 | 8.27 |
| 606 | Benign neoplasm: Colon, unspecified | FING00000172 | 8.25 |
| 607 | Benign neoplasm: Adrenal gland | FING00000164 | 8.25 |
| 608 | Heart failure and coronary heart disease | FING00000604 | 8.24 |
| 609 | Macular puckering of retina (PheCode 362.26) | GCST90475854 | 8.23 |
| 610 | Left-hemisphere somatomotor network to thalamus white-matter structural connectivity | GCST90302682 | 8.22 |
| 611 | Low hand grip strength (60 years and older) (EWGSOP) | GCST90007527 | 8.22 |
| 612 | FABP2/RBP2 ratio | GCST90314757 | 8.22 |
| 613 | SCARA5/TNC ratio | GCST90315810 | 8.22 |
| 614 | FAP/LRRN1 ratio | GCST90314783 | 8.21 |
| 615 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 41) | GCST90320860 | 8.21 |
| 616 | PKD1 levels | GCST90470240 | 8.21 |
| 617 | T1 FreeSurfer DK lh lingual thickness | GCST90385634 | 8.21 |
| 618 | Falls/tendency to fall | FING00000530 | 8.20 |
| 619 | aparc-DKTatlas rh area cuneus | GCST90003268 | 8.17 |
| 620 | BA-exvivo rh thickness BA4a | GCST90003531 | 8.17 |
| 621 | CHL1 levels | GCST90468745 | 8.17 |
| 622 | Eye autorefraction and astigmatism (confirmatory factor analysis Factor 24) | GCST90309358 | 8.16 |
| 623 | aparc-a2009s lh thickness G-precuneus | GCST90003632 | 8.15 |
| 624 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16) | GCST90320579 | 8.14 |
| 625 | Atherosclerosis of native arteries of the extremities with intermittent claudication (PheCode 440.22) | GCST90475991 | 8.13 |
| 626 | Osteoporosis NOS | musculoskeletal | UKBB00000599 | 8.13 |
| 627 | PTPRN2/RTBDN ratio | GCST90315754 | 8.12 |
| 628 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T10 | ECGU000010 | 8.12 |
| 629 | IFNGR1/THBD ratio | GCST90315130 | 8.11 |
| 630 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus R | GCST90004069 | 8.10 |
| 631 | Bioavailable testosterone levels | GCST90012104 | 8.10 |
| 632 | Phosphatidylcholine-O_36:2_[M+H]1+/Phosphatidylcholine-P_36:1_[M+H]1+/Phosphatidylethanolamine-P_39:1_[M+H]1+ levels | GCST90060326 | 8.09 |
| 633 | AIFM1/EGF ratio | GCST90313219 | 8.08 |
| 634 | DTI autoptx L3 unc l tract | GCST90385218 | 8.06 |
| 635 | high density lipoprotein cholesterol (HDLC, maximum, inv-norm transformed) | GCST90475348 | 8.05 |
| 636 | PSME2/RBKS ratio | GCST90315737 | 8.04 |
| 637 | Succinylcarnitine levels | GCST90243874 | 8.04 |
| 638 | DPP4/ITGB1 ratio | GCST90314540 | 8.03 |
| 639 | wg lh intensity-contrast caudalmiddlefrontal | GCST90003795 | 8.02 |
| 640 | aparc-a2009s rh area S-orbital-H-Shaped | GCST90003434 | 8.01 |
| 641 | PI16 levels | GCST90470229 | 8.01 |
| 642 | COL24A1 levels | GCST90468814 | 8.00 |
| 643 | DTI TBSS L2 Retrolenticular part of internal capsule L | GCST90384497 | 7.98 |
| 644 | Angina pectoris | Ischaemic heart diseases | UKBB00000031 | 7.97 |
| 645 | IDP dMRI TBSS L1 Superior fronto-occipital fasciculus R | GCST90004117 | 7.97 |
| 646 | DTI autoptx L2 unc l tract | GCST90385191 | 7.96 |
| 647 | wg lh intensity-contrast superiortemporal | GCST90003821 | 7.96 |
| 648 | Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk | FING00000150 | 7.95 |
| 649 | Volume of right paralaminar nucleus | GCST90475048 | 7.94 |
| 650 | PSG1 levels | GCST90470353 | 7.94 |
| 651 | Angina pectoris | circulatory system | UKBB00000030 | 7.93 |
| 652 | PRTG levels | GCST90470347 | 7.93 |
| 653 | Hydrocele | FING00000627 | 7.92 |
| 654 | IDP dMRI TBSS MD Retrolenticular part of internal capsule L | GCST90004048 | 7.91 |
| 655 | ThalamNuclei rh volume CeM | GCST90002751 | 7.90 |
| 656 | LEPR levels | GCST90469756 | 7.89 |
| 657 | IFIT2 levels | GCST90090864 | 7.89 |
| 658 | SPARCL1 levels | GCST90470717 | 7.87 |
| 659 | GFRA3 levels | GCST90469330 | 7.85 |
| 660 | SCARF2 levels | GCST90470537 | 7.85 |
| 661 | Spondylolisthesis/Spondylolysis | FING00001324 | 7.84 |
| 662 | COMP levels | GCST90468827 | 7.83 |
| 663 | Fracture of rib(s), sternum and thoracic spine | FING00000558 | 7.82 |
| 664 | Height (standard GWA) | GCST90267284 | 7.82 |
| 665 | Lysophosphatidylethanolamine-P_20:0_[M-H]1- levels | GCST90060147 | 7.82 |
| 666 | DLK1 levels | GCST90469003 | 7.81 |
| 667 | Glaucoma | GCST90468129 | 7.81 |
| 668 | Major coronary heart disease event | FING00000746 | 7.80 |
| 669 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475350 | 7.80 |
| 670 | IDP T1 FAST ROIs L front operc cortex | GCST90002531 | 7.80 |
| 671 | DTI TBSS L1 External capsule R | GCST90384460 | 7.79 |
| 672 | Arthropathies | FING00000107 | 7.78 |
| 673 | aparc-a2009s lh area G-cuneus | GCST90003307 | 7.78 |
| 674 | LAMB1 levels | GCST90469732 | 7.78 |
| 675 | MAVS/PPP1R9B ratio | GCST90315393 | 7.77 |
| 676 | Fracture of lower limb | injuries & poisonings | UKBB00000255 | 7.77 |
| 677 | Maximum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000428 | 7.76 |
| 678 | Triacylglycerol_46:4_[M+NH4]1+ levels | GCST90060362 | 7.75 |
| 679 | IDP dMRI ProbtrackX L3 ilf r | GCST90004315 | 7.74 |
| 680 | BA-exvivo lh thickness BA2 | GCST90003514 | 7.74 |
| 681 | Knee extension strength | GCST90319502 | 7.74 |
| 682 | Vascular/heart problems diagnosed by doctor - Heart attack | Medical conditions | UKBB00000897 | 7.73 |
| 683 | L1CAM levels | GCST90469723 | 7.72 |
| 684 | Fracture of lower leg, including ankle | FING00000555 | 7.72 |
| 685 | ANGPTL2 levels | GCST90468303 | 7.72 |
| 686 | Left-hemisphere default mode network to right-hemisphere visual network white-matter structural connectivity | GCST90302760 | 7.70 |
| 687 | IDP dMRI ProbtrackX MD ar l | GCST90004219 | 7.69 |
| 688 | BA-exvivo rh volume BA1 | GCST90002849 | 7.69 |
| 689 | Disorders of breast | FING00000437 | 7.69 |
| 690 | Prescriptions - angiotensin receptor blocker|anti-hypertensive|ARB | UKBB00000662 | 7.68 |
| 691 | Abnormalities of forces of labour | FING00000003 | 7.67 |
| 692 | IDP dMRI TBSS MD Pontine crossing tract | GCST90004028 | 7.66 |
| 693 | aparc-DKTatlas rh volume parahippocampal | GCST90002907 | 7.66 |
| 694 | Osteoporosis | GCST90086122 | 7.66 |
| 695 | Corneal dystrophy (PheCode 364.5) | GCST90475864 | 7.66 |
| 696 | RGMB/SMOC2 ratio | GCST90315770 | 7.66 |
| 697 | TPM2 levels | GCST90243122 | 7.65 |
| 698 | Cholesteryl ester (16:2) levels | GCST90024628 | 7.64 |
| 699 | CD79B/FCRL2 ratio | GCST90313900 | 7.63 |
| 700 | APOM levels | GCST90468342 | 7.62 |
| 701 | PON2/PON3 ratio | GCST90315703 | 7.62 |
| 702 | PECAM1/SOD2 ratio | GCST90315647 | 7.62 |
| 703 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 45) | GCST90320608 | 7.61 |
| 704 | Polyp of the female genital tract | FING00001190 | 7.60 |
| 705 | DTI TBSS L3 Superior corona radiata R | GCST90384548 | 7.58 |
| 706 | FABP5 levels | GCST90469177 | 7.58 |
| 707 | IDP T1 FAST ROIs R caudate | GCST90002550 | 7.58 |
| 708 | LILRB4 levels | GCST90426708 | 7.57 |
| 709 | Cataract | sense organs | UKBB00000120 | 7.57 |
| 710 | Coronary atherosclerosis | FING00000359 | 7.56 |
| 711 | Coronary artery / coronary heart disease (including heart attack, angina) | GCST90475198 | 7.56 |
| 712 | HMCN2 levels | GCST90469461 | 7.55 |
| 713 | Descending aorta strain | GCST90267389 | 7.54 |
| 714 | Retinal detachments and defects | sense organs | UKBB00000756 | 7.53 |
| 715 | Isoleucine levels (UKB data field 23465) | GCST90269562 | 7.53 |
| 716 | Triacylglycerol_49:3_[M+NH4]1+ levels | GCST90060443 | 7.51 |
| 717 | Ganglion and cyst of synovium, tendon, and bursa (PheCode 727.4) | GCST90476243 | 7.51 |
| 718 | 10-undecenoate (11:1n1) levels | GCST90243596 | 7.50 |
| 719 | CST3/IGFBP6 ratio | GCST90314293 | 7.49 |
| 720 | Glucose levels | GCST90132724 | 7.49 |
| 721 | NOTCH3 levels | GCST90470067 | 7.47 |
| 722 | C1QL2 levels | GCST90468487 | 7.46 |
| 723 | MATN2/SCARA5 ratio | GCST90315388 | 7.46 |
| 724 | IDP dMRI ProbtrackX L2 atr l | GCST90004275 | 7.45 |
| 725 | Endometriosis of ovary | FING00000501 | 7.45 |
| 726 | CR2/TNFRSF13B ratio | GCST90314225 | 7.45 |
| 727 | FAP/THBS4 ratio | GCST90314785 | 7.45 |
| 728 | Other predominantly sexually transmitted diseases, not elsewhere classified | FING00001089 | 7.44 |
| 729 | ICD10 C53: Malignant neoplasm of cervix uteri | GCST90454202 | 7.44 |
| 730 | CHCHD6 levels | GCST90468739 | 7.44 |
| 731 | APOM/MCAM ratio | GCST90313315 | 7.41 |
| 732 | Humerus length to body height ratio | GCST90270259 | 7.41 |
| 733 | Osteomyelitis, periostitis, and other infections involving bone (PheCode 710) | GCST90476220 | 7.39 |
| 734 | Triacylglycerol_50:4_[M+NH4]1+ levels | GCST90060466 | 7.39 |
| 735 | Knee osteoarthritis | GCST007090 | 7.39 |
| 736 | Phospholipids to total lipids in large VLDL percentage (UKB data field 23589) | GCST90269686 | 7.38 |
| 737 | Operation code - wisdom teeth surgery | Operations | UKBB00000569 | 7.37 |
| 738 | DTI TBSS L2 Posterior corona radiata R | GCST90384502 | 7.36 |
| 739 | IDP dMRI TBSS MD Cingulum cingulate gyrus R | GCST90004061 | 7.35 |
| 740 | Aspartate aminotransferase | Blood biochemistry | UKBB00000052 | 7.34 |
| 741 | End-diastolic bi-ventricular shape (principal component 4) | GCST90448483 | 7.33 |
| 742 | Right-hemisphere salience/ventral attention network to pallidum white-matter structural connectivity | GCST90302820 | 7.32 |
| 743 | NCR3 levels | GCST90088179 | 7.32 |
| 744 | HSPG2/VASN ratio | GCST90315094 | 7.31 |
| 745 | Follicular cysts of skin and subcutaneous tissue | FING00000547 | 7.31 |
| 746 | CCL8 levels | GCST90422346 | 7.30 |
| 747 | Pulmonary tuberculosis | GCST90018672 | 7.29 |
| 748 | CAG-177 sp003514385 abundance in stool | GCST90032259 | 7.29 |
| 749 | SERPINA3 levels | GCST90470583 | 7.28 |
| 750 | Dihexosylceramide (d18:1/22:0) levels | GCST90025348 | 7.28 |
| 751 | Minimum carotid IMT (intima-medial thickness) at 210 degrees | Carotid ultrasound | UKBB00000477 | 7.26 |
| 752 | aparc-DKTatlas lh area lingual | GCST90003245 | 7.25 |
| 753 | Heart valve replaced (PheCode 395.6) | GCST90475915 | 7.25 |
| 754 | Other chronic ischemic heart disease, unspecified (PheCode 411.8) | GCST90475938 | 7.25 |
| 755 | CREG1/NAAA ratio | GCST90314250 | 7.24 |
| 756 | aparc-Desikan lh area lingual | GCST90003085 | 7.23 |
| 757 | Urinary ethanolamine to urinary creatinine ratio | GCST90451717 | 7.23 |
| 758 | MYOC/NOTCH3 ratio | GCST90315507 | 7.21 |
| 759 | systolic blood pressure (SBP, maximum, inv-normal transformed) | GCST90476400 | 7.21 |
| 760 | Angina | GCST90468109 | 7.21 |
| 761 | High density lipoprotein cholesterol levels | GCST90278635 | 7.21 |
| 762 | Volume of right whole amygdala | GCST90474931 | 7.21 |
| 763 | Optic cup area | GCST004137 | 7.21 |
| 764 | aparc-pial rh area parstriangularis | GCST90003193 | 7.20 |
| 765 | IDP dMRI TBSS MD Retrolenticular part of internal capsule R | GCST90004047 | 7.19 |
| 766 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502166 | 7.18 |
| 767 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 52) | GCST90320871 | 7.15 |
| 768 | Childhood maltreatment | GCST90551844 | 7.15 |
| 769 | BA-exvivo lh thickness BA4p | GCST90003518 | 7.15 |
| 770 | IDP dMRI ProbtrackX L2 ifo l | GCST90004285 | 7.15 |
| 771 | Metabolic syndrome | GCST90444489 | 7.14 |
| 772 | Polycythemia, secondary (PheCode 289.8) | GCST90475822 | 7.14 |
| 773 | FNDC1 levels | GCST90469256 | 7.14 |
| 774 | Heart attack | GCST90468132 | 7.13 |
| 775 | Heart attack | GCST90475211 | 7.13 |
| 776 | Unstable angina pectoris | GCST90018712 | 7.12 |
| 777 | DTI TBSS FA Posterior corona radiata R | GCST90384406 | 7.12 |
| 778 | high density lipoprotein cholesterol (HDLC, mean, inv-norm transformed) | GCST90475352 | 7.11 |
| 779 | aseg global volume 4th-Ventricle | GCST90002600 | 7.10 |
| 780 | LGALS3 levels | GCST90179303 | 7.09 |
| 781 | CRH levels | GCST90468862 | 7.08 |
| 782 | NCS1/NPY ratio | GCST90315527 | 7.06 |
| 783 | IDP dMRI TBSS L3 Fornix | GCST90004176 | 7.06 |
| 784 | Fasciitis | musculoskeletal | UKBB00000239 | 7.05 |
| 785 | Occlusion and stenosis of precerebral arteries (PheCode 433.1) | GCST90475986 | 7.05 |
| 786 | GGCT levels | GCST90469334 | 7.05 |
| 787 | CD300LG levels | GCST90468623 | 7.04 |
| 788 | aparc-pial rh area lateraloccipital | GCST90003184 | 7.03 |
| 789 | Skin yellow/blue component | GCST90320259 | 7.01 |
| 790 | Intrahepatic cholestasis of pregnancy | GCST90454199 | 7.01 |
| 791 | Total body bone mineral density (age 45-60) | GCST005350 | 6.99 |
| 792 | Pulse wave reflection index | Arterial stiffness | UKBB00000726 | 6.99 |
| 793 | Epstein-Barr virus EA-D antibody levels | GCST90006898 | 6.98 |
| 794 | Polyarthrosis | FING00001181 | 6.98 |
| 795 | AGRN/BTN2A1 ratio | GCST90313199 | 6.97 |
| 796 | TP53I3 levels | GCST90470937 | 6.96 |
| 797 | CD200 levels | GCST90468606 | 6.95 |
| 798 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule R | GCST90004191 | 6.95 |
| 799 | wg rh intensity-contrast parstriangularis | GCST90003846 | 6.94 |
| 800 | TNFRSF4/TNFRSF9 ratio | GCST90315939 | 6.94 |
| 801 | Coronary atherosclerosis (PheCode 411.4) | GCST90475936 | 6.93 |
| 802 | LEPR/NTRK2 ratio | GCST90315313 | 6.93 |
| 803 | rfMRI connectivity ICA-features 4 | GCST90006342 | 6.93 |
| 804 | aparc-Desikan lh volume parsopercularis | GCST90002785 | 6.91 |
| 805 | Autorefraction - 6mm asymmetry angle (left) | Eyesight | UKBB00000072 | 6.91 |
| 806 | Ascending aorta diameter | GCST90091050 | 6.90 |
| 807 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 109) | GCST90320928 | 6.89 |
| 808 | IDP dMRI ProbtrackX L2 ifo r | GCST90004286 | 6.89 |
| 809 | BA-exvivo lh thickness BA1 | GCST90003513 | 6.88 |
| 810 | IDP T1 FAST ROIs L pallidum | GCST90002553 | 6.87 |
| 811 | Total protein levels | GCST90018756 | 6.87 |
| 812 | Operative procedures - Carpal tunnel release | Summary Operations | UKBB00000574 | 6.86 |
| 813 | Osteoporosis, osteopenia and pathological fracture | musculoskeletal | UKBB00000600 | 6.86 |
| 814 | EFNA1 levels | GCST90469080 | 6.84 |
| 815 | CPM levels | GCST90240598 | 6.83 |
| 816 | IDP dMRI TBSS MD Superior fronto-occipital fasciculus L | GCST90004070 | 6.82 |
| 817 | ROBO1/SPON1 ratio | GCST90315783 | 6.81 |
| 818 | CLUL1 levels | GCST90468792 | 6.79 |
| 819 | INHBB levels | GCST90469614 | 6.78 |
| 820 | rfMRI amplitudes (ICA100 node 40) | GCST90004628 | 6.78 |
| 821 | Ischemic heart disease (PheCode 411) | GCST90475929 | 6.77 |
| 822 | S100A12 levels | GCST90470513 | 6.77 |
| 823 | wg rh intensity-contrast parahippocampal | GCST90003842 | 6.77 |
| 824 | Enteritis due to Yersinia enterocolitica | FING00000505 | 6.77 |
| 825 | aparc-a2009s rh area Pole-occipital | GCST90003412 | 6.75 |
| 826 | ITGA2 levels | GCST90469634 | 6.75 |
| 827 | Systolic blood pressure (standard GWA) | GCST90267304 | 6.74 |
| 828 | Triglyceride to HDL cholesterol ratio | GCST90295949 | 6.74 |
| 829 | Nonalcoholic fatty liver disease | GCST90275041 | 6.73 |
| 830 | MPO levels | GCST90469937 | 6.73 |
| 831 | Spinal stenosis of lumbar region (PheCode 720.1) | GCST90476234 | 6.72 |
| 832 | Docosahexaenoic acid to total fatty acids percentage (UKB data field 23457) | GCST90269554 | 6.72 |
| 833 | CCL14 levels | GCST90468566 | 6.71 |
| 834 | Fibromuscular dysplasia | GCST90026612 | 6.70 |
| 835 | CAG-177 abundance in stool | GCST90032261 | 6.69 |
| 836 | aparc-DKTatlas lh area cuneus | GCST90003237 | 6.69 |
| 837 | Torso length to body height ratio | GCST90270262 | 6.69 |
| 838 | Haematocrit percentage (UKB data field 30030) | GCST90468073 | 6.66 |
| 839 | CCN3/PGF ratio | GCST90313722 | 6.66 |
| 840 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 93) | GCST90320912 | 6.65 |
| 841 | Triacylglycerol_53:5_[M+NH4]1+ levels | GCST90060520 | 6.65 |
| 842 | F3 levels | GCST90469170 | 6.65 |
| 843 | FSTL3/SPON2 ratio | GCST90314884 | 6.64 |
| 844 | X-24337 levels | GCST90200629 | 6.63 |
| 845 | Cholesteryl Esters in HDL | GCST90497368 | 6.63 |
| 846 | IDP dMRI TBSS L2 Cingulum hippocampus R | GCST90004159 | 6.63 |
| 847 | CD70 levels | GCST90468645 | 6.60 |
| 848 | Osteomyelitis (PheCode 710.1) | GCST90476221 | 6.59 |
| 849 | N-acetyl-2-aminoadipate levels | GCST90200268 | 6.59 |
| 850 | IDP dMRI TBSS MD Fornix | GCST90004032 | 6.59 |
| 851 | IDP dMRI TBSS L3 Sagittal stratum L | GCST90004202 | 6.58 |
| 852 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320691 | 6.57 |
| 853 | Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453) | GCST90269550 | 6.57 |
| 854 | Phospholipids in large HDL (UKB data field 23560) | GCST90269657 | 6.57 |
| 855 | Coronary artery bypass grafting | FING00000358 | 6.57 |
| 856 | RBP2 levels | GCST90470438 | 6.57 |
| 857 | IDP dMRI ProbtrackX MD atr l | GCST90004221 | 6.57 |
| 858 | IDP dMRI ProbtrackX OD str r | GCST90004474 | 6.56 |
| 859 | Phospholipids in large VLDL | GCST90498243 | 6.56 |
| 860 | Triglycerides to phosphoglycerides ratio (UKB data field 23435) | GCST90269532 | 6.56 |
| 861 | ACVRL1/TNFRSF19 ratio | GCST90313159 | 6.54 |
| 862 | CDHR2 levels | GCST90468679 | 6.54 |
| 863 | rfMRI amplitudes (ICA100 node 27) | GCST90004615 | 6.54 |
| 864 | NEO1 levels | GCST90470029 | 6.53 |
| 865 | CLMP/TGFBR2 ratio | GCST90314135 | 6.53 |
| 866 | Total testosterone levels | GCST90239820 | 6.52 |
| 867 | NAAA levels | GCST90469991 | 6.52 |
| 868 | CD40LG/TNFSF14 ratio | GCST90313827 | 6.51 |
| 869 | LTBR levels | GCST90243176 | 6.51 |
| 870 | Acetabular diameter | GCST90448906 | 6.49 |
| 871 | aparc-DKTatlas rh area lateraloccipital | GCST90003274 | 6.49 |
| 872 | Endometriosis | GCST90018619 | 6.48 |
| 873 | IDP dMRI ProbtrackX L3 ifo l | GCST90004312 | 6.47 |
| 874 | Pulse pressure | GCST90018750 | 6.47 |
| 875 | Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels | GCST90200017 | 6.46 |
| 876 | ISLR2 levels | GCST90469629 | 6.45 |
| 877 | IDP dMRI ProbtrackX MD ilf r | GCST90004234 | 6.45 |
| 878 | Left ventricular wall thickness (maximal) | GCST90435263 | 6.43 |
| 879 | IDP dMRI TBSS L3 Cerebral peduncle R | GCST90004185 | 6.42 |
| 880 | Delta body mass index (difference between ECG-predicted and measured) | GCST90429062 | 6.42 |
| 881 | HAMP levels | GCST90451683 | 6.39 |
| 882 | Phospholipids to Total Lipids in Large HDL percentage | GCST90497863 | 6.39 |
| 883 | high density lipoprotein cholesterol (HDLC, minimm, inv-norm transformed) | GCST90475356 | 6.39 |
| 884 | Phosphatidylcholine-O_34:2_[M+H]1+/Phosphatidylcholine-P_34:1_[M+H]1+/Phosphatidylethanolamine-O_37:2_[M+H]1+ levels | GCST90060280 | 6.38 |
| 885 | PARK7/TNFRSF9 ratio | GCST90315599 | 6.38 |
| 886 | HDL cholesterol levels | GCST90497352 | 6.37 |
| 887 | Nonspecific elevation of levels of transaminase or lactic acid dehydrogenase [LDH] (PheCode 573.6) | GCST90476094 | 6.37 |
| 888 | Phospholipids to total lipids ratio in large VLDL | GCST90092877 | 6.37 |
| 889 | Inguinal hernia | GCST90018648 | 6.36 |
| 890 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502580 | 6.36 |
| 891 | Diarrhoea and gastroenteritis of presumed infectious origin | FING00000420 | 6.35 |
| 892 | DSG4 levels | GCST90469044 | 6.35 |
| 893 | ANGPTL3/TFPI ratio | GCST90313270 | 6.35 |
| 894 | Takes medication for coronary artery/ coronary heart disease? | GCST90475199 | 6.34 |
| 895 | PLA2G15/PRCP ratio | GCST90315661 | 6.34 |
| 896 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 101) | GCST90320920 | 6.33 |
| 897 | Systolic blood pressure | GCST90301695 | 6.33 |
| 898 | AHCY/HSPA1A ratio | GCST90313211 | 6.33 |
| 899 | Triglycerides in very large VLDL (UKB data field 23494) | GCST90269591 | 6.32 |
| 900 | ALB levels | GCST90497101 | 6.30 |
| 901 | KDR/VWF ratio | GCST90315245 | 6.29 |
| 902 | aparc-a2009s rh area S-collat-transv-ant | GCST90003420 | 6.28 |
| 903 | Concentration of chylomicrons and extremely large VLDL particles (UKB data field 23481) | GCST90269578 | 6.28 |
| 904 | Prescriptions - anti-malarial | UKBB00000663 | 6.28 |
| 905 | Prescriptions - quinine bisulfate | anti-malarial | UKBB00000698 | 6.28 |
| 906 | End-diastolic bi-ventricular shape (principal component 5) | GCST90448484 | 6.27 |
| 907 | IDP dMRI ProbtrackX L1 ptr l | GCST90004265 | 6.27 |
| 908 | Cholesteryl Esters to Total Lipids in Large HDL percentage | GCST90497763 | 6.25 |
| 909 | IL17D levels | GCST90469560 | 6.25 |
| 910 | Ascending aorta strain | GCST90267388 | 6.24 |
| 911 | SLC39A5 levels | GCST90470661 | 6.24 |
| 912 | aseg rh intensity Thalamus-Proper | GCST90003782 | 6.23 |
| 913 | COL6A3 levels | GCST90468821 | 6.23 |
| 914 | Total lipids in very large VLDL (UKB data field 23489) | GCST90269586 | 6.22 |
| 915 | NXPH3 levels | GCST90470112 | 6.21 |
| 916 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 6.21 |
| 917 | PPP2R2A levels | GCST90618122 | 6.19 |
| 918 | Cholesteryl esters in chylomicrons and extremely large VLDL (UKB data field 23485) | GCST90269582 | 6.19 |
| 919 | aparc-Desikan lh area cuneus | GCST90003077 | 6.19 |
| 920 | Hypermetropia (PheCode 367.8) | GCST90475882 | 6.17 |
| 921 | aparc-Desikan rh area lateraloccipital | GCST90003117 | 6.17 |
| 922 | 4-hydroxyglutamate levels | GCST90199890 | 6.17 |
| 923 | aparc-DKTatlas rh thickness cuneus | GCST90003574 | 6.16 |
| 924 | Total lipids in large HDL | GCST90497815 | 6.15 |
| 925 | Chronic Kidney Disease, Stage IV (PheCode 585.34) | GCST90476130 | 6.14 |
| 926 | Spinal stenosis (PheCode 720) | GCST90476233 | 6.13 |
| 927 | Coronary atherosclerosis | circulatory system | UKBB00000152 | 6.13 |
| 928 | C3 levels | GCST90468498 | 6.13 |
| 929 | ITGAV levels | GCST90469639 | 6.13 |
| 930 | MEGF9 levels | GCST90469884 | 6.12 |
| 931 | Cholesterol in chylomicrons and extremely large VLDL (UKB data field 23484) | GCST90269581 | 6.12 |
| 932 | Left-hemisphere salience/ventral attention network to thalamus white-matter structural connectivity | GCST90302719 | 6.12 |
| 933 | CDH5/ENG ratio | GCST90313954 | 6.11 |
| 934 | Osteoarthritis | GCST90468144 | 6.10 |
| 935 | Phospholipids in chylomicrons and extremely large VLDL (UKB data field 23483) | GCST90269580 | 6.09 |
| 936 | Noninflammatory disorders of female genital tract | FING00000882 | 6.09 |
| 937 | IDP dMRI TBSS FA Tapetum L | GCST90003924 | 6.09 |
| 938 | Diverticular disease of intestine | FING00000471 | 6.08 |
| 939 | Hammer toe (acquired) (PheCode 735.21) | GCST90476250 | 6.08 |
| 940 | GDNF levels | GCST90469323 | 6.08 |
| 941 | Volume of right cortico-amygdaloid transition area | GCST90474913 | 6.07 |
| 942 | Macular cyst | FING00000743 | 6.07 |
| 943 | BMPER levels | GCST90468455 | 6.06 |
| 944 | DTI TBSS L2 Uncinate fasciculus L | GCST90384521 | 6.06 |
| 945 | F7/VASN ratio | GCST90314745 | 6.06 |
| 946 | Pulse wave peak to peak time | Arterial stiffness | UKBB00000725 | 6.05 |
| 947 | CD48 levels | GCST90425676 | 6.05 |
| 948 | IDP T1 FAST ROIs L cuneal cortex | GCST90002513 | 6.05 |
| 949 | Dry age-related macular degeneration (includes geographic atrophy) | FING00000480 | 6.05 |
| 950 | aparc-a2009s rh area S-central | GCST90003415 | 6.05 |
| 951 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 6.04 |
| 952 | Bone marrow fat fraction of left proximal femur | GCST90652392 | 6.03 |
| 953 | Other headache syndromes | FING00001055 | 6.02 |
| 954 | aparc-a2009s rh thickness G-cuneus | GCST90003687 | 6.01 |
| 955 | DTI autoptx L3 str l tract | GCST90385216 | 6.01 |
| 956 | rfMRI connectivity (ICA100 edge 380) | GCST90005233 | 6.01 |
| 957 | TXN levels | GCST90470995 | 6.00 |
| 958 | Metabolic disorder, other/unspecified | FING00000815 | 6.00 |
| 959 | DAB2/TBL1X ratio | GCST90314368 | 6.00 |
| 960 | PTPRM levels | GCST90470384 | 5.99 |
| 961 | CNTN5 levels | GCST90468807 | 5.99 |
| 962 | X-25371 levels | GCST90200656 | 5.98 |
| 963 | Valvular heart disease excluding rheumatic fever | FING00001414 | 5.98 |
| 964 | Serine levels | GCST90200415 | 5.97 |
| 965 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T37 | ECGU000037 | 5.97 |
| 966 | C-reactive protein levels (CRP.4337.49.2) | GCST90240503 | 5.97 |
| 967 | IDP dMRI ProbtrackX MD cgc l | GCST90004223 | 5.96 |
| 968 | TGFBR3 levels | GCST90470848 | 5.96 |
| 969 | NHLRC3 levels | GCST90470046 | 5.96 |
| 970 | Illnesses of siblings - Heart disease | Family history | UKBB00000351 | 5.95 |
| 971 | Cholesterol to Total Lipids in Large HDL percentage | GCST90497730 | 5.95 |
| 972 | RBP7 levels | GCST90470440 | 5.95 |
| 973 | Average diameter for HDL particles | GCST90497454 | 5.93 |
| 974 | Non-cancer illness code, self-reported - angina | Medical conditions | UKBB00000505 | 5.93 |
| 975 | aparc-Desikan rh volume parstriangularis | GCST90002820 | 5.92 |
| 976 | CFB levels | GCST90240778 | 5.92 |
| 977 | Endometriosis | FING00000497 | 5.91 |
| 978 | Cholesterol in Medium HDL | GCST90498495 | 5.90 |
| 979 | MOG/RTBDN ratio | GCST90315476 | 5.90 |
| 980 | FAM3B/FGF19 ratio | GCST90314776 | 5.90 |
| 981 | FOXJ3 levels | GCST90469264 | 5.89 |
| 982 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 125) | GCST90320944 | 5.89 |
| 983 | Physical function (baseline) | GCST90565837 | 5.89 |
| 984 | Nonalcoholic fatty liver disease | GCST90054782 | 5.88 |
| 985 | Chronic obstructive pulmonary disease | GCST90018587 | 5.87 |
| 986 | CR2 levels | GCST90468852 | 5.86 |
| 987 | CPXM2 levels | GCST90468850 | 5.86 |
| 988 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 81) | GCST90320644 | 5.85 |
| 989 | Lymphoid leukemia, chronic (PheCode 204.12) | GCST90475613 | 5.85 |
| 990 | IDP dMRI ProbtrackX MD cst l | GCST90004227 | 5.83 |
| 991 | IDP dMRI TBSS L2 Fornix | GCST90004128 | 5.83 |
| 992 | IDP dMRI TBSS L2 Pontine crossing tract | GCST90004124 | 5.82 |
| 993 | CTSZ/NAAA ratio | GCST90314320 | 5.82 |
| 994 | Volume of left lateral nucleus | GCST90474970 | 5.82 |
| 995 | HDL cholesterol | Blood biochemistry | UKBB00000306 | 5.82 |
| 996 | GGT5 levels | GCST90469337 | 5.82 |
| 997 | IDP dMRI ProbtrackX FA ifo r | GCST90003938 | 5.81 |
| 998 | Triglyceride to phosphoglyceride ratio | GCST90499996 | 5.81 |
| 999 | Hair/balding pattern: Pattern 4 (UKB data field 2395_4) | GCST90043619 | 5.80 |
| 1000 | Thoracic or lumbosacral neuritis or radiculitis, unspecified (PheCode 763) | GCST90476268 | 5.79 |